In tumors, IL33 has also been found to be involved in the tumor’s pro-oncogenic and anti-oncogenic functions, with its main effects focused on the immune microenvironment, immune occurrence, and tumor-related inflammation (Shen et al., 2018). This evidence concerns the gene IL33 and neoplasm.